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S U M M A R Y
Objective: To determine whether there is an association between the species of Streptococcus anginosus
group (SAG) bacteria and the clinical outcome.
Methods: Isolates from invasive infections caused by SAG bacteria at our institution between January
2004 and February 2009 were identiﬁed phenotypically to the taxonomic level of species. Clinical data
from the medical records of the patients from whom these isolates were recovered were obtained
retrospectively and analyzed.
Results: Patients with invasive Streptococcus intermedius infections had a signiﬁcantly longer hospital
stay than patients infected with S. anginosus (p = 0.024) and a signiﬁcantly higher 30-day all-cause
mortality than patients infected with Streptococcus constellatus (p = 0.049).
Conclusion: Identiﬁcation of SAG bacteria to the taxonomic level of species may be of prognostic
importance.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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The Streptococcus anginosus (SAG) group of bacteria (previously
known as the Streptococcus milleri group) includes Streptococcus
anginosus, Streptococcus intermedius, and Streptococcus constellatus.
These organisms are commensal ﬂora of the human oropharynx
and gastrointestinal tract, but they also have the capacity to cause
severe invasive infections with a propensity for dissemination and
abscess formation.1 Historically, S. anginosus has been found to be
the species most frequently isolated from clinically signiﬁcant
specimens and S. intermedius the least common.2–5
Identiﬁcation of SAG bacteria to the taxonomic level of species
is not routinely performed in most microbiology laboratories. This
is in part because currently available phenotypic identiﬁcation
methods are often unable to provide precise results, but also
because SAG bacteria are predictably susceptible to penicillin6–8
and therefore speciation is generally not considered necessary for
patient management. We reviewed invasive infections due to SAG       
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http://dx.doi.org/10.1016/j.ijid.2013.09.003bacteria at our institution over a 5-year period to determine
whether there was an association between the species identiﬁed
and the presenting clinical syndrome, disease severity, and
outcome.
2. Materials and methods
2.1. Clinical data collection
Invasive SAG infections that occurred over a 5-year period
(January 2004 to February 2009) at the Sir Charles Gairdner
Hospital (a 650-bed adult tertiary referral center in Perth, Western
Australia) were identiﬁed retrospectively from a database of sterile
site isolates maintained at PathWest Laboratory Medicine, Queen
Elizabeth II Medical Centre, Perth, Western Australia. The medical
records of patients from whom isolates were obtained were
reviewed. An invasive SAG infection was deﬁned as a case where
SAG bacteria were cultured from a specimen(s) obtained from a
normally sterile site; cultures of upper respiratory tract swabs,
wound swabs, urine, and sputum were excluded.
The following demographic and clinical data were obtained
from the medical records: age at diagnosis, sex, presenting
symptoms, co-morbidities (Charlson index),9 details of recent
surgery, vital signs, white cell count, C-reactive protein, renal and
liver function (using the most abnormal values obtained within theociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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Simpliﬁed Acute Physiology II Score (SAPS II) was calculated for
each patient as an estimate of illness severity at presentation.10
Thirty-day mortality was determined from the hospital clinical
information system that is linked to the Western Australian
Registry of Deaths.
Invasive SAG infections were classiﬁed into the following
speciﬁc clinical syndromes: bacteremia (primary or secondary),
bone and/or soft tissue infection, central nervous system infection,
intra-abdominal infection, respiratory infection, and infective
endocarditis. Primary bacteremia was deﬁned as a blood culture
yielding SAG bacteria without an identiﬁable source. Secondary
bacteremia was deﬁned as a positive blood culture for SAG bacteria
in the setting of an identiﬁable primary focus of infection.
2.2. Laboratory methods
Isolates that had previously been identiﬁed as SAG in the
routine diagnostic microbiology laboratory were recovered from
80 8C storage in glycerol. Thawed suspensions were cultured on
horse blood agar (HBA) and incubated at 37 8C in 6% CO2 for 48 h
and checked for purity. Colony features typical of SAG were
observed, including the presence of a caramel odor, hemolysis, and
cellular morphology on Gram stain, and representative colonies
were subcultured onto HBA and re-incubated for 24 h in 6% CO2.
Subsequent testing to exclude non-SAG bacteria was performed
using the catalase test, rapid biochemical tests, and Lanceﬁeld
grouping using a commercial latex particle agglutination test.
Isolates provisionally identiﬁed as SAG bacteria were subse-
quently analyzed in three separate phenotypic identiﬁcation
systems routinely used in diagnostic microbiology laboratories:
the API-20 and Rapid-ID 32 Strep test strips and the VITEK GPI
card/VITEK 2 system (bioMe´rieux, France). If two or three of the
identiﬁcation systems identiﬁed the isolate as a particular species
within the SAG at 50% probability, then the isolate was classiﬁed
as that species.
2.3. Statistical methods
Medians were compared using the Student’s t-test or the
Wilcoxon non-parametric test when appropriate. Similarly,
percentages were compared with the Pearson’s Chi-square test
or Fisher’s exact test. Multiple group comparison was done with
the Kruskal–Wallis test. A p-value of less than 0.05 was consideredTable 1
Demographic and clinical features of patients with invasive Streptococcus anginosus gro
S. anginosus
(n = 31), n (%)
S
(n
Mean age, years 49.5 
Male sex 18 (58) 
CRP (mg/l), mean (range) 206 (1.5–490) 2
Mean Charlson score 1.2 
SAPS II, mean (range) 23.2 (6–63) 
HDU/ICU admission 9 (29) 
Type of infection
Bacteremia 9 (29) 
Intra-abdominal 17 (55) 
Bone/soft tissue 4 (13) 
Respiratory 5 (16) 
CNS 0 (0) 
Endocarditis 3 (10) 
LOS (days), median (range) 10.0 (1–40) 
Dead at 30 days 3 (10) 
CRP, C-reactive protein; SAPS II, Simpliﬁed Acute Physiology II Score; HDU, high depende
NS, not signiﬁcant.
a Statistical signiﬁcance achieved when comparing S. anginosus and S. intermedius.
b Statistical signiﬁcance achieved when comparing S. constellatus and S. intermedius.signiﬁcant. All statistical analyses were performed using the PASW
Statistics 18.0 software package (SPSS Inc., Chicago, IL, USA).
3. Results
Seventy-six isolates were stored in the sterile site culture
collection as SAG bacteria over the period of the study. Of these,
two were found not to be SAG bacteria and ﬁve isolates were
deemed not to be invasive isolates. Ten isolates represented second
or subsequent isolates from the same patient and three isolates
contained two different species of SAG bacteria. Data presented
hereafter are for the 56 discrete episodes of invasive infection due
to a single species of SAG bacteria. Of these, 31 (55.4%) were
identiﬁed as S. anginosus, 16 (28.6%) as S. constellatus, and nine
(16.0%) as S. intermedius.
Twenty-three of the 56 specimens (41%) that contained a single
species of SAG bacteria also cultured other bacteria: 13/31 (42%) in
the S. anginosus group, 9/16 (56%) in the S. constellatus group, and 1/
9 (11%) in the S. intermedius group. The majority of these isolates
(15 out of 23) were cultured from intra-abdominal specimens and
were commonly mixed with anaerobes and Enterobacteriaceae
(data not shown). Two episodes of co-infection with S. constellatus
and Staphylococcus aureus occurred in patients with bone and soft
tissue infection.
When the demographic and clinical features of patients with
invasive S. anginosus, S. intermedius, and S. constellatus infections
were compared (Table 1), a male predominance was noted in all
three groups and all were of similar mean age. As expected, intra-
abdominal (48%) and respiratory infections, including lung
abscesses and empyema (23%), were the most commonly
identiﬁed clinical syndromes. Bacteremia was observed in 13
cases: nine due to S. anginosus and four due to S. constellatus, with
11 secondary bacteremia and two primary bacteremia. We found
that bacteremia occurred most frequently in S. anginosus infec-
tions, occurring in 29% of cases. Similarly, S. anginosus was the only
species isolated in the three cases of infective endocarditis. Central
nervous system infection was uncommon in this study (n = 2), with
S. intermedius isolated in both of these cases. The number of
positive isolates from a respiratory source was proportionally
highest in the S. intermedius group, comprising 56% of all S.
intermedius isolates. Mean Charlson index scores and SAPS II scores
were comparable throughout all groups. The median hospital
length of stay was 18 days for S. intermedius, 10.5 days for S.
constellatus, and 10 days for S. anginosus. The median hospitalup infections
. constellatus
 = 16), n (%)
S. intermedius
(n = 9), n (%)
p-Value
53.2 59.8 NS
10 (62) 6 (67) NS
90 (100–610) 195 (11–340) NS
2.1 1.8 NS
20.2 (0–39) 24.7 (10–42) NS
3 (19) 3 (33) NS
4 (25) 0 (0) NS
9 (56) 1 (11) NS
3 (19) 1 (11) NS
3 (19) 5 (56) NS
0 (0) 2 (22) NS
0 (0) 0 (0) NS
10.5 (4–199) 18 (8–37) p = 0.024a
0 (0) 2 (22) p = 0.049b
ncy unit; ICU, intensive care unit; CNS, central nervous system; LOS, length of stay;
R.K. Junckerstorff et al. / International Journal of Infectious Diseases 18 (2014) 38–4040length of stay of patients with S. intermedius infection was
signiﬁcantly longer than that of patients with S. anginosus infection
(p = 0.024).
Fifty-one of 56 (91%) patients with invasive SAG infection were
alive at 30 days following hospital admission. The ﬁve patients
who died did so during their initial hospitalization. Three deaths
occurred in the S. anginosus group and two in the S. intermedius
group. None of the 16 patients infected with S. constellatus died.
Thirty-day mortality in patients with S. intermedius infection was
signiﬁcantly higher than that of patients with S. constellatus
infection (p = 0.049).
4. Discussion
Previous studies have suggested that different species within
the SAG bacteria are associated with speciﬁc clinical syndromes,
although the data are somewhat conﬂicting. A review of 153
clinical isolates of SAG bacteria found that S. anginosus was the
predominant strain isolated in intra-abdominal infections, where-
as S. intermedius was associated with central nervous system
infections, particularly brain abscesses.2 Two later studies
conﬁrmed the association of S. anginosus with the gastrointestinal
tract, however also discovered that S. intermedius was isolated
more frequently from purulent head and neck specimens.3,4 It has
also been suggested that there is an association between S.
constellatus and thoracic infection.11 These associations between
species of SAG bacteria and speciﬁc clinical syndromes, however,
were not demonstrated in a recent review of 245 clinical isolates of
SAG bacteria. The only association the authors found was a higher
relative representation of S. constellatus among blood culture
isolates.12 Our study did not demonstrate any statistically
signiﬁcant correlation between species and site of infection.
There is a paucity of data in the published literature evaluating
clinical outcomes of patients with invasive SAG bacterial infec-
tions, in particular the morbidity and mortality attributable to
individual subspecies. Pooled data of seven studies of 215 patients
with SAG bacteremia found an all-cause mortality rate of 16%.12
Three of these studies looked at the mortality associated with each
of the three species of SAG bacteria.12–14 Jacobs et al. found that of
19 cases of SAG bacteremia, 15 were caused by S. anginosus, of
which ﬁve died.13 Similarly, an Israeli study of 28 episodes of SAG
bacteremia found that 19 were caused by S. anginosus and that the
three deaths that occurred came from this cohort.12 In contrast, a
review of 30 cases of SAG bacteremia performed by Casariego and
colleagues found that the three patients who died were infected
with S. constellatus. Only two of the 30 patients were infected with
S. anginosus, neither of whom died.14
To our knowledge, our study represents the largest evaluation
of clinical outcomes of patients with invasive SAG bacterial
infections reported in the literature. We were unable to demon-
strate any statistically signiﬁcant difference between the three
species of SAG bacteria with regards to the severity of infection on
presentation (as represented by SAPS II) or likelihood of admission
to the intensive care unit/high dependency unit. In contrast, 30-
day mortality and median length of hospital stay were signiﬁcantly
higher/longer in the S. intermedius group than in patients infected
with S. constellatus and S. anginosus, respectively. This is in spite of
S. anginosus and S. constellatus being much more common causes of
bacteremia than S. intermedius.
This study has several important limitations. Firstly, it was a
retrospective single-center study with a relatively small samplesize. Secondly, a signiﬁcant proportion of invasive SAG episodes in
this study were polymicrobial, although this reﬂects what is
commonly observed in clinical practice. Thirdly, we did not collect
data on antimicrobial therapy or other interventions that may
affect patient outcome (e.g., surgical drainage of abscesses),
however there should be no reason why this should differ between
SAG species.
The signiﬁcantly longer length of stay and higher 30-day
mortality of patients infected with S. intermedius in this study
suggests that identiﬁcation of SAG bacteria to the taxonomic level
of species is of potential prognostic importance. Prospective
studies are needed to ascertain whether infection with a speciﬁc
species of SAG is a predictor of infection severity and clinical
outcome.
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